Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
Hand-out
Press Releases
January 7, 2025

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

TransCode shares to remain listed on Nasdaq

bradford

The Bradford Era

Local & Social